Theophylline with ciprofloxacin increases risk of toxicity due to decreased clearance. What is the recommended action?

Study for the AGS Beers Criteria Test. Prepare with flashcards and multiple choice questions, each with hints and explanations. Get ready for your exam with comprehensive resources!

Multiple Choice

Theophylline with ciprofloxacin increases risk of toxicity due to decreased clearance. What is the recommended action?

Explanation:
The main concept here is that some drug pairs can cause serious toxicity when one drug affects the clearance of another. Theophylline is cleared mainly by CYP1A2, and ciprofloxacin inhibits this enzyme. When ciprofloxacin is added, theophylline isn’t cleared as quickly, so its levels rise and toxicity risk increases. That heightened risk is the reason for changing therapy: avoid the combination or use a non-interacting antibiotic, or closely monitor and adjust theophylline dosing if no alternatives exist. So saying that theophylline toxicity risk is increased correctly identifies the consequence of the interaction and justifies taking preventive action.

The main concept here is that some drug pairs can cause serious toxicity when one drug affects the clearance of another. Theophylline is cleared mainly by CYP1A2, and ciprofloxacin inhibits this enzyme. When ciprofloxacin is added, theophylline isn’t cleared as quickly, so its levels rise and toxicity risk increases. That heightened risk is the reason for changing therapy: avoid the combination or use a non-interacting antibiotic, or closely monitor and adjust theophylline dosing if no alternatives exist. So saying that theophylline toxicity risk is increased correctly identifies the consequence of the interaction and justifies taking preventive action.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy